Picture of Takara Bio logo

4974 — Takara Bio News Story

0.000.00%
jp flag iconLast trade - 00:00
HealthcareBalancedMid CapNeutral

Table: Takara Bio -Q1 group results

Aug 6 (Reuters)- 
             Takara Bio Inc. 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 3 months ended      3 months ended       Year to 
                Jun 30, 2021        Jun 30, 2020     Mar 31, 2022 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales             15.27               6.94             54.20    
                (+120.1 pct)         (-19.8 pct)      (+17.6 pct) 
  Operating          8.50              693 mln           17.00    
                                     (-69.2 pct)      (+21.8 pct) 
  Recurring          8.58              745 mln           17.10    
                                     (-66.1 pct)      (+20.8 pct) 
  Net                6.03              404 mln           11.90    
                                     (-74.6 pct)      (+24.6 pct) 
  EPS             50.04 yen           3.36 yen         98.82 yen  
  Ann Div                             16.00 yen        20.00 yen  
  -Q2 div                                NIL              NIL     
  -Q4 div                             16.00 yen        20.00 yen  
  
  NOTE - Takara Bio Inc.. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4974.T

Recent news on Takara Bio

See all news